COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia - Concepedia

Concepedia

Publication | Closed Access

COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia

14

Citations

12

References

2018

Year

Kristina Klupsch, Vanessa Baeriswyl, Roland W. Scholz, Joana Dannenberg, Roger Santimaria, David Senn, Elena Kage, Adrian Zumsteg, Isabella Attinger-Toller, Ulrike von der Bey,

Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematologyPharmacologyImmunologyIgg-like PharmacokineticsImmunotherapyOncologyCancer ResearchMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1